[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353716-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353716-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-dual-role-of-the-notch-signaling-pathway-in-digestive-system-cancers","The dual role of the Notch signaling pathway in digestive system cancers","","The Notch signaling pathway is essential for maintaining tissue homeostasis and shows dual functions in digestive system cancers, acting as both an oncogene and a tumor suppressor. The review examines diverse roles across esophageal, gastric, liver, pancreatic, and colorectal cancers. It highlights context-dependent tumor inhibition and progression in esophageal and pancreatic tumors, distinct drivers in hepatocellular carcinoma via DLL4/Notch1 and Jag1/Notch2, and colon cancer effects on immune evasion and anti-tumor immunity. It emphasizes limitations of broad γ-secretase inhibitors and calls for precision, biomarker-driven, subtype-specific inhibitors and combination strategies targeting the tumor microenvironment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-dual-role-of-the-notch-signaling-pathway-in-digestive-system-cancers/353716/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-dual-role-of-the-notch-signaling-pathway-in-digestive-system-cancers/353716.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What dual roles does Notch signaling play in digestive system cancers?","Question",{"text":63,"@type":64},"Notch signaling maintains tissue homeostasis but can act as both an oncogene and a tumor suppressor gene. Its effects vary by cancer type and cellular context.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does Notch signaling influence tumor growth in esophageal and pancreatic cancers?",{"text":68,"@type":64},"In esophageal and pancreatic cancers, Notch signaling may initially inhibit tumor growth and later promote progression. The direction of effect is influenced by the primary cell types involved.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are broad γ-secretase inhibitors challenging, and what future strategies are suggested?",{"text":72,"@type":64},"Broad-spectrum γ-secretase inhibitors often cause considerable side effects, creating therapeutic challenges. Future strategies should prioritize precision medicine, including subtype-specific Notch receptor inhibitors, biomarker-driven personalized therapies, and combination treatments that modify the tumor microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353716,1790188923,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Xiang et al. European Journal  \nEuropean Journal of Medical Research (2026) 31:328  \n[https://doi.org/10.1186/s40001-026-03947-3](https://doi.org/10.1186/s40001-026-03947-3 of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-026-03947-3 of Medical Research)  \n REVIEW Open Access  \nThe dual role of the Notch signaling pathway in digestive system cancers  \nDairong Xiang1,2†, Tuokai Wang1,2†, Shihui Wei1,2, Ruihong Zhao1,2, Lanjuan Li 1,2* and Juan Lu 1,2*  \nAbstract  \nThe Notch signaling pathway is critical for maintaining tissue homeostasis and plays dual roles in digestive system cancers, acting both as an oncogene and a tumor suppressor gene. This article explores its varied functions across esophageal, gastric, liver, pancreatic, and colorectal cancers. In esophageal and pancreatic cancers, Notch signaling may initially inhibit tumor growth but later promote progression, influenced by the primary cell types. In hepatocellular carcinoma, DLL4/Notch1 generally drives tumor growth, whereas Jag1/Notch2 tends to suppress tumor progression. In colon cancer, this pathway not only facilitates immune evasion but, in the presence of specific mutations, can also enhance the anti-tumor immune response. The functional complexity of Notch signaling presents significant therapeutic challenges, as broad-spectrum γ-secretase inhibitors (GSIs) are often associated with considerable side effects. Future treatment strategies should prioritize precision medicine, including subtype-specific Notch receptor inhibitors, biomarker-driven personalized therapies, and combination treatments aimed at modifying the tumor microenvironment. A thorough understanding of these dual roles is significant for developing more accurate and effective treatment approaches for digestive system cancers.  \nKeywords Notch signaling, Digestive system cancers, Dual role, Tumor microenvironment, Targeted therapy  \nIntroduction  \nThe global burden of digestive system cancers remains substantial. In 2021, malignancies of the digestive system accounted for 39.29% of cancer-related deaths, making them the leading cause of cancer mortality. This  \n†Dairong Xiang and Tuokai Wang have contributed equally to this work.  \n*Correspondence: Lanjuan Li[ljli@zju.edu.cn](ljli@zju.edu.cn)[ ](ljli@zju.edu.cn)Juan Lu[lujuanzju@zju.edu.cn](lujuanzju@zju.edu.cn)  \n1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n2 Yuhang Institute of Medical Science Innovation and Transformation, Hangzhou, Zhejiang, China  \ncategory includes gastric, colorectal, and esophageal cancers. The age-standardized mortality rates (ASDR) for colorectal and gastric cancers were 12.40 and 11.20 per 100,000 people, respectively, ranking among the top four causes of cancer death [1, 2]. Significant differences in age, gender, socio-economic status, dietary habits, and geographical distribution pose challenges for personalized treatment strategies. Given the limitations of current diagnostic technologies and therapeutic agents, investigating the mechanisms of carcinogenesis and progression, as well as identifying new therapeutic targets, is  \nessential for improving patient survival rates [3–7].  \nAs research advances, treatment strategies have evolved from standardized approaches to precision medicine and immunotherapy [8, 9]. The Notch signaling pathway is a highly conserved mechanism across multicellular organisms [10–16]. First identified in 1917 through the study of Drosophila mutants, its molecular characterization was completed in 1983 [17, 18]. The Notch signaling cascade plays a pivotal regul","cbCaisEo6CtA6Aj1","https://ap.wps.com/l/cbCaisEo6CtA6Aj1","pdf",1484280,18,"English","# Introduction\n## Global burden of digestive system cancers\n## Precision medicine and immunotherapy context\n## Overview of Notch signaling pathway\n# Abstract\n# Keywords","[{\"question\":\"What dual roles does Notch signaling play in digestive system cancers?\",\"answer\":\"Notch signaling maintains tissue homeostasis but can act as both an oncogene and a tumor suppressor gene. Its effects vary by cancer type and cellular context.\"},{\"question\":\"How does Notch signaling influence tumor growth in esophageal and pancreatic cancers?\",\"answer\":\"In esophageal and pancreatic cancers, Notch signaling may initially inhibit tumor growth and later promote progression. The direction of effect is influenced by the primary cell types involved.\"},{\"question\":\"Why are broad γ-secretase inhibitors challenging, and what future strategies are suggested?\",\"answer\":\"Broad-spectrum γ-secretase inhibitors often cause considerable side effects, creating therapeutic challenges. Future strategies should prioritize precision medicine, including subtype-specific Notch receptor inhibitors, biomarker-driven personalized therapies, and combination treatments that modify the tumor microenvironment.\"}]","The dual role of the Notch signaling pathway in digestive system cancers | PDF",1790106931,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b2826fa083bd9f23e73af71f4427f53.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7af4b40cfd3915cad064320584276581.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ead26cfb6ce927d0fdcc63cf0a49e16d.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/911d6a5600eddda9b5b83f0331fc4350.webp",980,1301]